CVS Health saw the highest growth of 2.49% in patent filings in May and 1.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of CVS Health‘s patent filings and grants. Buy the databook here.
CVS Health has been focused on protecting inventions in United States(US) with 11 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 57% grants. The United States(US), and Canada(CA) patent Office are among the top ten patent offices where CVS Health is filings its patents. Among the top granted patent authorities, CVS Health has 57% of its grants in United States(US) and 43% in Canada(CA).
International Business Machines and Siemens could be the strongest competitors for CVS Health
Patents related to artificial intelligence and machine learning lead CVS Health's portfolio
CVS Health has the highest number of patents in artificial intelligence followed by, machine learning and data science. For artificial intelligence, nearly 20% of patents were filed and 14% of patents were granted in Q2 2024.
Mos micro (mpu, mcu & dsp) related patents lead CVS Health portfolio followed by machine learning, and autonomous driving
CVS Health has highest number of patents in mos micro (mpu, mcu & dsp) followed by machine learning, autonomous driving, electronic document mgmt, and online retail. For mos micro (mpu, mcu & dsp), nearly 20% of patents were filed and 12% of patents were granted in Q2 2024.
For comprehensive analysis of CVS Health's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.